Plant Health Care plc (LON:PHC) CEO Dr Chris Richards talks to DirectorsTalk about it’s interim results for the 6 months ended 30th June 2018. Chris talks us through the highlights, the increase traction seen in Brazil, the launch of Harpin aβ in corn in the USA, updates us on the Brazilian soybeans trials, expands on the pilot-scale production of improved peptide formulations and product registrations and shares his view on the prospects for PHC over the next two years.
Plant Health Care plc is a leading provider of scientifically proven biological products for the agricultural industry. The Company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, cotton and rice, as well as specialty crops such as fruits and vegetables.
Its innovative line of patent protected products provides both economic and environmental benefits for its customers and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and growth. PHC has global reach through operating subsidiaries and supply agreements with major industry partners.
